300357 Zhejiang Wolwo Bio-Pharmaceutical
- 23.79
- -0.32-1.33%
Zhejiang Wolwo Bio-Pharmaceutical News
Wushu Biotech: 2021 Annual Equity Distribution Implementation Notice
Our martial arts biotechnology: Announcement on the 2021 profit distribution plan
Weiwu Biotech: Announcement on the acquisition of part of the shares of participating companies and increasing their capital
Wowu Biotech: 3. Supplemental Legal Opinion on Zhejiang Wowu Biotechnology Co., Ltd. issuing A-share shares to specific targets in 2020 (1)
Wowu Biotech: 1. Response report of Zhejiang Wowu Biotechnology Co., Ltd. and Everbright Securities Co., Ltd. to the audit inquiry letter on the application to issue A-shares to specific targets (revised draft) (1)
Wowu Biotech: 2 Response to the Enquiry Letter of Ernst & Young Huaming Certified Public Accountants (Special General Partnership) on Zhejiang Wowu Biotechnology Co., Ltd.'s application to issue shares to specific targets
Wushu Biotech: 3-3 Listing Sponsorship Letter (Application Draft)
Wushu Creatures: 1-1 Recruiting Instructions (Application Draft)
Weiwu Biotech: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
Wowu Biotech: Audit inquiry letter on Zhejiang Wowu Biotechnology Co., Ltd.'s application to issue shares to specific targets
Weifang Biotech: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Wushu Biotech: 3-3 Listing Sponsorship Letter (Application Draft)
Weifu Biotech: 4-1 Legal Opinion (Application Draft)
Wushu Creatures: 1-1 Recruiting Instructions (Application Draft)
Weiwu Biotech: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
We Wu Biotech: Announcement on the controlling shareholder's non-public offering of exchangeable corporate bonds to obtain a letter of no objection from the Shenzhen Stock Exchange
Announcement on the listing and trading of Zhejiang Wowu Biotechnology Co., Ltd. shares on the GEM
Weiwu Biotech: China Securities Regulatory Commission's approval for the company's initial public offering of shares and listing on the GEM
Analysis
Price Target
No Data
No Data